[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363123-105":59,"doc-detail-363123-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","a-novel-nomogram-incorporating-the-aggregate-index-of-systemic-inflammation-clinicopathological-parameters-and-molecular-classification-to-predict-recurrence-of-endometrial-cancer-a-multi-center-retrospective-study","A Novel Nomogram Incorporating the Aggregate Index of Systemic Inflammation, Clinicopathological Parameters and Molecular Classification to Predict Recurrence of Endometrial Cancer - A Multi-Center Retrospective Study","","This multi-center retrospective study assessed the aggregate index of systemic inflammation (AISI) as a predictor of postoperative recurrence in endometrial cancer (EC). A total of 1557 patients were included and split into training (n=1030) and validation (n=527) cohorts. ROC analysis determined the optimal AISI cutoff, and multivariate Cox regression identified eight independent recurrence-free survival factors (all p\u003C0.05). A prognostic nomogram integrating these variables was constructed and externally validated, showing improved accuracy over conventional approaches. The nomogram also supported adjuvant therapy benefit in high-risk patients, enabling refined risk stratification and personalized treatment planning.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-novel-nomogram-incorporating-the-aggregate-index-of-systemic-inflammation-clinicopathological-parameters-and-molecular-classification-to-predict-recurrence-of-endometrial-cancer-a-multi-center-retrospective-study/363123/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-novel-nomogram-incorporating-the-aggregate-index-of-systemic-inflammation-clinicopathological-parameters-and-molecular-classification-to-predict-recurrence-of-endometrial-cancer-a-multi-center-retrospective-study/363123.png","ImageObject",300,407,{"name":92,"@type":93},"Cipher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of this study in endometrial cancer?","Question",{"text":112,"@type":113},"To evaluate whether the aggregate index of systemic inflammation (AISI), combined with clinicopathological and molecular factors, can predict postoperative recurrence in endometrial cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patients grouped for model development and testing?",{"text":117,"@type":113},"The study included 1557 patients, divided into a training cohort (n=1030) and a validation cohort (n=527).",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors were independently associated with recurrence-free survival?",{"text":121,"@type":113},"Multivariate Cox regression identified eight independent recurrence-free survival factors, including age ≥60, FIGO stage III, LVSI, CA125 ≥35 U/mL, deep myometrial invasion, histological type II, p53 abnormality, and high AISI.",{"name":123,"@type":110,"acceptedAnswer":124},"How does the nomogram improve clinical decision-making?",{"text":125,"@type":113},"The validated nomogram provides superior predictive accuracy versus conventional methods and helps identify high-risk patients who may benefit from adjuvant therapy, supporting risk stratification and personalized planning.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},363123,1790204862,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},687208528416,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Cancer Medicine  \n|  RESEARCH ARTICLE  OPEN ACCESS \u003Cbr>A Novel Nomogram Incorporating the Aggregate Index of Systemic Inflammation, Clinicopathological Parameters and Molecular Classification to Predict Recurrence of Endometrial Cancer: A Multi-Center Retrospective Study\u003Cbr>Chenfan Tian1 | Na Zeng2 | Yuan Tu1 | Chunxia Gong3 | Jiaxin Yu1 | Kunying Rao2 | Peng Jiang1 \u003Cbr>1Chongqing Key Laboratory of Maternal and Fetal Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical, Chongqing, China | 2Department of Obstetrics and Gynecology, The People's Hospital of Yubei District of Chongqing, Chongqing, China | 3Department of Obstetrics and Gynecology, Women and Children's Hospital of Chongqing Medical University, Chongqing, China\u003Cbr>Correspondence: Kunying Rao ([343056795@qq.com](343056795@qq.com)) | Peng Jiang ([jiangpeng1106@hospital.cqmu.edu.cn](jiangpeng1106@hospital.cqmu.edu.cn))\u003Cbr>Received: 4 November 2025 | Revised: 3 April 2026 | Accepted: 12 April 2026\u003Cbr>Keywords: aggregate index of systemic inflammation | endometrial cancer | molecular classification | nomogram | prognosis |  |\n| --- | --- |\n| ABSTRACT\u003Cbr>This study evaluated the aggregate index of systemic inflammation (AISI) for predicting postoperative recurrence in endometrial cancer (EC). A total of 1557 patients were enrolled and divided into training (n = 1030) and validation (n = 527) cohorts. The optimal AISI cutoff was determined by ROC curve analysis. Multivariate Cox regression identified eight independent prognostic factors for recurrence-free survival (all p \u003C 0.05): age ≥60 (HR = 1.683, 95% CI 1.191–2.377), FIGO stage III (HR = 2.346, 95% CI 1.480–3.718), LVSI (HR = 1.792, 95% CI 1.226–2.618), CA125 ≥35 U/mL (HR = 1.457, 95% CI 1.030–2.062), deep myometrial invasion (HR = 2.021, 95% CI 1.393–2.930), histological type II (HR = 1.798, 95% CI 1.219–2.653), p53 abnormal (HR = 3.252, 95% CI 2.142–4.936), and high AISI (HR = 2.492, 95% CI 1.714–3.625). A prognostic nomogram incorporating these factors was constructed and validated, demonstrating superior predictive accuracy compared to conventional methods. Adjuvant therapy significantly improved outcomes in high-risk patients identified by the nomogram. This comprehensive tool enhances risk stratification and may guide personalized treatment planning. |  |\n| 1 | Introduction | annually, making EC the sixth most frequently diagnosed cancer among women [2] . Estimates for the United States in 2023 |\n| Endometrial cancer (EC) is one of the most common gyneco- | projected approximately 66,200 new cases and 13,030 deaths |\n| logical malignancies worldwide and is associated with a high | [3] . In China, EC is the second most common malignancy of |\n| mortality rate, posing a significant public health challenge for | the female reproductive system; the 2022 age-standardized |\n| women [1] . According to 2022 global cancer statistics, there | incidence rate was approximately 6.84 per 100,000 women, |\n| were approximately 420,242 new cases and 97,704 deaths | and the age-standardized mortality rate was approximately |\n| Abbreviations: AISI, aggregate index of systemic inflammation; BMI, body mass index; EC, endometrial cancer; ESGO, European Society of Gynecological Oncology; FIGO, International Federation of Gynecology and Obstetrics; LVSI, lymphovascular space invasion; MLR, monocyte-to-lymphocyte ratio; MMR, mismatch repair; MMR-D, mismatch repair-deficient; NCCN, National Comprehensive Cancer Network; NGS, next-generation sequencing; NLR, neutrophil-to-lymphocyte ratio; p53 abn, p53 abnormal; p53 wt, p53 wild-type; PLR, platelet-to-lymphocyte ratio; ProMisE, Proactive Molecular Risk Classifier for Endometrial Cancer; RFS, recurrence-free survival; SIRI, systemic inflammation response index; TCGA, The Cancer Genome Atlas; VBT, vaginal brachytherapy; WHO, World Health Organization; WPRT, whole pelvic radiotherapy.\u003Cbr>Chenfan Tian and Na Zeng contributed equally to this work ","cbCaio5x6KGm61of","https://ap.wps.com/l/cbCaio5x6KGm61of","pdf",3073614,13,"English","# Introduction\n# Methods\n## Study population and cohorts\n## AISI cutoff determination\n## Statistical modeling and validation\n# Results\n## Independent prognostic factors\n## Nomogram construction and performance\n# Discussion\n## Clinical implications and adjuvant therapy guidance","[{\"question\":\"What is the main objective of this study in endometrial cancer?\",\"answer\":\"To evaluate whether the aggregate index of systemic inflammation (AISI), combined with clinicopathological and molecular factors, can predict postoperative recurrence in endometrial cancer.\"},{\"question\":\"How were patients grouped for model development and testing?\",\"answer\":\"The study included 1557 patients, divided into a training cohort (n=1030) and a validation cohort (n=527).\"},{\"question\":\"Which factors were independently associated with recurrence-free survival?\",\"answer\":\"Multivariate Cox regression identified eight independent recurrence-free survival factors, including age ≥60, FIGO stage III, LVSI, CA125 ≥35 U/mL, deep myometrial invasion, histological type II, p53 abnormality, and high AISI.\"},{\"question\":\"How does the nomogram improve clinical decision-making?\",\"answer\":\"The validated nomogram provides superior predictive accuracy versus conventional methods and helps identify high-risk patients who may benefit from adjuvant therapy, supporting risk stratification and personalized planning.\"}]","A Novel Nomogram Incorporating the Aggregate Index of Systemic Inflammation, Clinicopathological Parameters and Molecular Classification to Predict Recurrence of Endometrial Cancer - A Multi-Center Retrospective Study | PDF",1790150093,33,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0a20085bf4be996a84dc5e616d1dec5.webp",983,1291,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0801e433ded38c8e6ad6e11ef8d240b9.webp",982,1290,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e41769803a3d4a0294c022bc52a0ce70.webp",981,1289,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6be21b2a7a36b46efb6c1034e215776.webp",980,1287]